At a glance
ClinicalIndex Comparison RecordN/AActive· 1,000 enrolled / 1,000 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
In Brief
An observational study for Carcinoma, Non-Small-Cell Lung and 9 related conditions. Active but no longer recruiting, targeting 1,000 participants across 46 sites.
Detailed Summary
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP; To evaluate the treatment pattern in metastatic NSCLC patients after QIP.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCarcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Diseases, Carcinoma, Bronchogenic, Bronchial Neoplasms
CountriesChina
Collaborators--
Timeline
N/AActive
2025202620272028
First PostedJul 2024
Enrollment StartNov 2024
TodayJul 2026
Primary CompletionNov 2027
First PostedJul 10, 2024
Enrollment StartNov 22, 2024
Primary CompletionNov 28, 2027
TodayJul 1, 2026
Enrollment to primary: 3.0 yearsPosted 2.0 years agoPrimary completion in 1.4 years